2021 Covid-19 Vaccines and Clinical Trials Update
In December we published a report on up and coming Covid-19 Vaccines from around the world. This month we are publishing an update on approved Covid 19 Vaccines and promising Covid-19 Vaccine candidates that have reached phase 3 clinical trials. We have indicated background information, Trial Design, their status for each.
This report is co-published with the drug regulatory consultancy SPharm and provided to you in a format that is hopefully useful to digest. All vaccine information, clinical trial data, summaries, content and references have been referenced directly from clinicaltrials.gov provided by the National Institutes of Health, by the Regulatory Affairs Professionals Society (RAPS), the New York Times Coronavirus Vaccine Tracker, by Health Canada and by CNN Health.
Download the 2021 Covid-19 Vaccines report now
TAKE THE NEXT STEP
Have any questions about your clinical trial design, protocol, or data? Ask our experts for their input or guidance. We are happy to help.
Need ballpark pricing, a comprehensive proposal, an RFP/RFI filled, review of your design, data or your development plan?
Download whitepapers, eGuides, infographics, presentations, articles and other relevant content from our resource center.